1. Home
  2. CDT vs FGI Comparison

CDT vs FGI Comparison

Compare CDT & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • FGI
  • Stock Information
  • Founded
  • CDT 2019
  • FGI 1987
  • Country
  • CDT United States
  • FGI United States
  • Employees
  • CDT 7
  • FGI N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • FGI Industrial Specialties
  • Sector
  • CDT Health Care
  • FGI Industrials
  • Exchange
  • CDT Nasdaq
  • FGI Nasdaq
  • Market Cap
  • CDT 9.0M
  • FGI 9.4M
  • IPO Year
  • CDT N/A
  • FGI 2022
  • Fundamental
  • Price
  • CDT $0.07
  • FGI $0.80
  • Analyst Decision
  • CDT
  • FGI
  • Analyst Count
  • CDT 0
  • FGI 0
  • Target Price
  • CDT N/A
  • FGI N/A
  • AVG Volume (30 Days)
  • CDT 16.2M
  • FGI 10.0K
  • Earning Date
  • CDT 02-14-2025
  • FGI 11-11-2024
  • Dividend Yield
  • CDT N/A
  • FGI N/A
  • EPS Growth
  • CDT N/A
  • FGI N/A
  • EPS
  • CDT N/A
  • FGI N/A
  • Revenue
  • CDT N/A
  • FGI $127,180,460.00
  • Revenue This Year
  • CDT N/A
  • FGI $11.39
  • Revenue Next Year
  • CDT N/A
  • FGI $6.26
  • P/E Ratio
  • CDT N/A
  • FGI N/A
  • Revenue Growth
  • CDT N/A
  • FGI 7.71
  • 52 Week Low
  • CDT $0.06
  • FGI $0.70
  • 52 Week High
  • CDT $5.44
  • FGI $1.85
  • Technical
  • Relative Strength Index (RSI)
  • CDT 40.15
  • FGI 45.90
  • Support Level
  • CDT $0.08
  • FGI $0.75
  • Resistance Level
  • CDT $0.09
  • FGI $0.89
  • Average True Range (ATR)
  • CDT 0.01
  • FGI 0.06
  • MACD
  • CDT -0.00
  • FGI 0.00
  • Stochastic Oscillator
  • CDT 27.18
  • FGI 35.71

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.

Share on Social Networks: